Molecular Biology Enzymes, Reagents and Kits Market Worth $29.3 Billion by 2027: Grand View Research, Inc.

·6 min read

SAN FRANCISCO, Aug. 18, 2022 /PRNewswire/ -- The global molecular biology enzymes, reagents and kits market size is expected to reach USD 29.3 billion by 2027, expanding at a CAGR of 11.0%, according to a new report by Grand View Research, Inc. The molecular biology field holds great potential to advance the medical treatments based on increasing scientific knowledge of cellular processes coupled with improving access to proteomics and genomics data.

Grand View Research Logo
Grand View Research Logo

Key Industry Insights & Findings from the report:

  • Kits and reagents dominated the market in terms of revenue share in 2019 due to the availability of reagents and kits at low cost and their repetitive use in routine laboratory workflows.

  • The presence of numerous domestic and international manufacturers offering kits and reagents coupled with the low cost incurred in the manufacturing of reagents are factors driving the market.

  • The completion of the Human Genome Project and a decline in the sequencing cost have broadened the use of sequencing technology in the molecular biology industry.

  • Next-generation Sequencing (NGS) is increasingly being employed for the determination of variants in rare and genetic diseases as well as molecular diagnosis of genetic disorders.

  • These factors contribute to an extensive application of molecular products in NGS technology, thus resulting in a larger share for sequencing in 2019.

  • Pharma and biotech is the highest revenue-generating end-use segment in 2019 and is expected to witness the fastest CAGR during the forecast period.

  • This is due to the wide implementation of PCR and NGS for the development of companion diagnostics and diagnostic tests, especially for the assessment of infectious diseases.

  • In the Asia Pacific, the is projected to witness the fastest growth rate during the forecast period with China as the fastest growing pharmaceutical market globally.

  • Expansion of the pharmaceutical industry along with an increase in the investments from global pharmaceutical firms is expected to boost the market growth in China.

  • In November 2019, AstraZeneca launched an R&D center and AI innovation center in Shanghai. This initiative is expected to drive the usage of molecular biology products in the pharma sector in China.

  • Major players, such as Thermo Fisher, Roche, Illumina, QIAGEN, and Bio-Rad, have undertaken several strategic initiatives to reinforce their market share.

  • For instance, in May 2020, Roche acquired Stratos Genomics that allowed Roche to advance the development of its nanopore sequencer using Sequencing by Expansion (SBX), the unique chemistry technology of the Stratos Genomics.


Read 275-page market research report, "Molecular Biology Enzymes, Reagents And Kits Market Size, Share & Trends Analysis Report By Product, By Application (Restriction Digestion, Sequencing, Cloning), By End-use, By Region, And Segment Forecasts, 2020 - 2027", published by Grand View Research.

Molecular Biology Enzymes, Reagents and Kits Market Growth & Trends

Personal genome sequencing is also expected to gain traction in the development of tailored diagnostics for each patient. A confluence of these factors drives the demand for molecular biology enzymes, reagents, and kits in the expansion of advanced personalized treatments.

Market players are engaged in constant product launches to enhance the efficiency of existing techniques and generate molecular information more easily, rapidly, and accurately. For instance, in June 2020, PCR Biosystems introduced a 4x RT-qPCR kit, qPCRBIO Probe 1-Step Virus Detect, designed for high-throughput, ultra-sensitive detection of viral RNA sequences, such as coronavirus. This new kit is proven to offer successful research in diagnostic projects.

Besides, synthetic biology is a rapidly advancing biotechnology field, which applies robust, innovative methods for drug manufacturing, cell therapies, and clinical diagnostics. Funding initiatives in this field expand its applications, which boost the usage of molecular biology products in these applications. As per SynBioBeta data, 37 synthetic biology companies raised USD 1.2 billion in the second quarter and 65 synthetic biology firms received USD 1.9 million funding in the first quarter of 2019.

Molecular Biology Enzymes, Reagents and Kits Market Segmentation

Grand View Research has segmented the global molecular biology enzymes, reagents, and kits market on the basis of product, application, end-use, and region:

Molecular Biology Enzymes, Reagents & Kits Market - Product Outlook (Revenue, USD Million, 2016 - 2027)

  • Kits & Reagents

  • Enzymes

Molecular Biology Enzymes, Reagents & Kits Market - Application Outlook (Revenue, USD Million, 2016 - 2027)

  • Cloning

  • Sequencing

  • PCR

  • Epigenetics

  • Restriction Digestion

  • Other Applications

Molecular Biology Enzymes, Reagents & Kits Market - End-use Outlook (Revenue, USD Million, 2016 - 2027)

  • Pharma & Biotech

  • Academic & Research

  • Hospital & Diagnostics

  • Others

Molecular Biology Enzymes, Reagents & Kits Market - Regional Outlook (Revenue, USD Million, 2016 - 2027)

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa (MEA)

List of Key Players of Molecular Biology Enzymes, Reagents and Kits Market

  • Thermo Fisher Scientific, Inc.


  • Illumina, Inc.

  • F. Hoffmann-La Roche Ltd.

  • Agilent Technologies, Inc.

  • Bio-Rad Laboratories, Inc.

  • New England Biolabs

  • Merck KGaA

  • Promega Corporation

  • Takara Bio, Inc.

  • LGC Limited

Check out more related studies published by Grand View Research:

  • Synthetic Biology Market - The global synthetic biology market size is expected to reach USD 55,371.1 million by 2030, registering a CAGR of 19.7% during the forecast period, according to a new report by Grand View Research, Inc. The presence of government and private funding to support research in vaccines and a strong synthetic biologic-based product pipeline in clinical trials are the key driving factors for the market.

  • Biotechnology Reagents & Kits Market - The global biotechnology reagents & kits market size is expected to reach USD 1.14 trillion by 2028, registering a CAGR of 16.5% over the forecast period, according to a new report by Grand View Research, Inc. Key factors driving the market include the introduction of novel and advanced products, a rise in investments in the biotechnology sector, and increasing demand for synthetic biology.

  • RNA Analysis Market - The global RNA analysis market size is anticipated to reach USD 42.30 billion by 2030, expanding at a CAGR of 16.59% from 2022 to 2030, according to a new report by Grand View Research, Inc. Transcriptomics is one of the most advanced fields in the post-genomic period. Technological advancements in this industry can be attributed to the increasing applications of transcriptome sequencing in life science for capturing polyadenylated RNA.

Browse through Grand View Research's Biotechnology Industry Research Reports.

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.


Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Grand View Compass | Astra ESG Solutions
Follow Us: LinkedIn | Twitter



View original content:

SOURCE Grand View Research, Inc.